Literature DB >> 166692

Studies on the regulation of the concentration of androgens and androgen receptors in nuclei of prostatic cells.

N Bruchovsky, P S Rennie, A Vanson.   

Abstract

Experiments were performed to assess the effect of intracellular androgen metabolism and the availability of cytoplasmic receptors on the concentration of androgens and androgen receptors in nuclei of prostatic cells. It was found that androgens are incorporated into the nucleus by a regulated, selective process which appears to limit the type and amount of androgen transported across the nuclear membrane. The metabolic conversion of testosterone to dihydrotestosterone which takes place in cytoplasm does not reduce transport and, very likely, affects only the ratio of testosterone and dihydrotestosterone transferred into the nucleus. In vivo, when the intranuclear concentration of androgens approaches 250 nM (8 pmol per mg DNA), an apparent concentration ceiling is reached even in the presence of a downward concentration gradient that would be expected to promote further transport across the nuclear membrane. This finding strongly suggests that in vivo the nuclear membrane acts as a barrier to the passage of androgens and, therefore, mitigates against the possibility that passive diffusion is an important mechanism of afferent transport of androgens into the nucleus. The ability of the nucleus to concentrate testosterone and dihydrotestosterone was clearly demonstrated in vivo when cytoplasmic concentrations of androgens of approximately 20 nM were accompanied by intranuclear concentrations in the vicinity of 250 nM. Since the measured concentration of testosterone and dihydrotestosterone in prostate of several species fall within the 5-20 nM range, it is evident that androgen concentrations in the nucleus as high as 250 nM may be typical of the physiological steady state. At the latter concentration the nucleus contains 60 000 androgen molecules: in approximate terms one third of this total is bound to a large molecular weight component of the nucleus, one third is bound to a 3.3 S receptor and one third is free or loosely bound. Since 60 000 androgen molecules and 20 000 receptor molecules appear in the nucleus before transport stops, it seems that the quantity of 4.4 S cytoplasmic receptor estimated at 174 plus or minus 24 pmol per mg protein (equivalent to about 8000 molecules per cell) is insufficient to account for the total influx of androgens and androgen receptors into the nucleus. Thus, although these results support the view that cytoplasmic receptors and the capacity to transport androgens are closely linked phenotypic markers of intracellular steroid hormone action, they suggest that the control of androgen concentration in the nucleus is achieved in a more intricate fashion than simply through a dependence on the presumed translocation of 4.4 S androgen-receptor complex into the nucleus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166692     DOI: 10.1016/0005-2736(75)90263-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  The relationship between adrogen receptors and the hormonally controlled responses of rat ventral prostate.

Authors:  E Van Doorn; S Craven; N Bruchovsky
Journal:  Biochem J       Date:  1976-10-15       Impact factor: 3.857

2.  Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells.

Authors:  Richard E Sobel; Yuzhuo Wang; Marianne D Sadar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jan-Feb       Impact factor: 2.416

3.  Trans-4-hydroxy-3-methoxycinnamic acid (ferulic acid) inhibits the effect of androgens on the rat prostate.

Authors:  T Saito; T Nohno; H Yoshida; H Yokoya
Journal:  Experientia       Date:  1979-05-15

4.  Steroid receptors in human prostatic cancer a preliminary evaluation.

Authors:  H J de Voogt; P Dingjan
Journal:  Urol Res       Date:  1978

5.  Radioimmunoassay measurements of nuclear dihydrotestosterone in rat prostate. Relationship to androgen receptors and androgen-regulated responses.

Authors:  M A De Larminat; P S Rennie; N Bruchovsky
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

6.  Studies on the role of the sex-hormone-binding globulin (SHBG) in prostatic gland hypertrophy in men. II. In vitro research.

Authors:  A Pachman
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.